Jill E Slansky

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 16

Top Topics

Acute Myeloid Leukemia

Breast Cancer Cells

Top Venues

Journal of immunology (Baltimore, Md. : 1950)

Molecular cancer research : MCR

The New England journal of medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Zachary L Z Hay, Dale D Kim, Jennifer M Cimons, Jennifer R Knapp, M Eric Kohler, Mary Quansah, Tiffany M Zúñiga, Faye A Camp, Mayumi Fujita, Xiao-Jing Wang, Brian P O'Connor, Jill E Slansky
Granzyme F: Exhaustion Marker and Modulator of Chimeric Antigen Receptor T Cell-Mediated Cytotoxicity. Journal of immunology (Baltimore, Md. : 1950) 212 (8) (2024)
Zachary L Z Hay, Dale D Kim, Jennifer M Cimons, Jennifer R Knapp, M Eric Kohler, Mary Quansah, Tiffany M Zúñiga, Faye A Camp, Mayumi Fujita, Xiao-Jing Wang, Brian P O'Connor, Jill E Slansky
Granzyme F: Exhaustion Marker and Modulator of Chimeric Antigen Receptor T Cell-Mediated Cytotoxicity. Journal of immunology (Baltimore, Md. : 1950) 212 (8) (2024)
Zachary L Z Hay, Dale D Kim, Jennifer M Cimons, Jennifer R Knapp, M Eric Kohler, Mary Quansah, Tiffany M Zúñiga, Faye A Camp, Mayumi Fujita, Xiao-Jing Wang, Brian P O'Connor, Jill E Slansky
Granzyme F: Exhaustion Marker and Modulator of Chimeric Antigen Receptor T Cell-Mediated Cytotoxicity. Journal of immunology (Baltimore, Md. : 1950) (2024)
Zachary L Z Hay, Dale D Kim, Jennifer M Cimons, Jennifer R Knapp, M Eric Kohler, Mary Quansah, Tiffany M Zúñiga, Faye A Camp, Mayumi Fujita, Xiao-Jing Wang, Brian P O'Connor, Jill E Slansky
Granzyme F: Exhaustion Marker and Modulator of Chimeric Antigen Receptor T Cell-Mediated Cytotoxicity. Journal of immunology (Baltimore, Md. : 1950) 212 (8) (2024)
Zachary L Z Hay, Jennifer R Knapp, Roman E Magallon, Brian P O'Connor, Jill E Slansky
Low TCR binding strength results in increased progenitor-like CD8+ tumor-infiltrating lymphocytes. Cancer immunology research (2023)
Faye A Camp, Tonya M Brunetti, Michelle M Williams, Jessica L Christenson, Varsha Sreekanth, James C Costello, Zachary L Z Hay, Ross M Kedl, Jennifer K Richer, Jill E Slansky
Antigens Expressed by Breast Cancer Cells Undergoing EMT Stimulate Cytotoxic CD8 + T Cell Immunity. Cancers 14 (18) (2022)
Zachary L Z Hay, Jill E Slansky
Granzymes: The Molecular Executors of Immune-Mediated Cytotoxicity. International journal of molecular sciences 23 (3) (2022)
Michelle M Williams, Jessica L Christenson, Kathleen I O'Neill, Sabrina A Hafeez, Claire L Ihle, Nicole S Spoelstra, Jill E Slansky, Jennifer K Richer
MicroRNA-200c restoration reveals a cytokine profile to enhance M1 macrophage polarization in breast cancer. NPJ breast cancer 7 (1) (2021)
Faye A Camp, Jill E Slansky
Implications of Antigen Selection on T Cell-Based Immunotherapy. Pharmaceuticals (Basel, Switzerland) 14 (10) (2021)
Peng-Cheng Wei, Kimberley R Jordan, Jonathan D Buhrman, Jun Lei, Hexiang Deng, Philippa Marrack, Shaodong Dai, John W Kappler, Jill E Slansky, Lei Yin
Structures suggest an approach for converting weak self-peptide tumor antigens into superagonists for CD8 T cells in cancer. Proceedings of the National Academy of Sciences of the United States of America 118 (23) (2021)
Kimberly R Jordan, Matthew J Sikora, Jill E Slansky, Angela Minic, Jennifer K Richer, Marisa R Moroney, Junxiao Hu, Rebecca J Wolsky, Zachary L Watson, Tomomi M Yamamoto, James C Costello, Aaron Clauset, Kian Behbakht, T Rajendra Kumar, Benjamin G Bitler
The Capacity of the Ovarian Cancer Tumor Microenvironment to Integrate Inflammation Signaling Conveys a Shorter Disease-free Interval. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (23) (2020)
Michele M Hoffmann, Jill E Slansky
T-cell receptor affinity in the age of cancer immunotherapy. Molecular carcinogenesis 59 (7) (2020)
Joseph A Westrich, Daniel W Vermeer, Alexa Silva, Stephanie Bonney, Jennifer N Berger, Louis Cicchini, Robert O Greer, John I Song, David Raben, Jill E Slansky, John H Lee, William C Spanos, Dohun Pyeon
CXCL14 suppresses human papillomavirus-associated head and neck cancer through antigen-specific CD8+ T-cell responses by upregulating MHC-I expression. Oncogene 38 (46) (2019)
Jennifer L Rabe, Lori Gardner, Rae Hunter, Jairo A Fonseca, Jodi Dougan, Christy M Gearheart, Michael S Leibowitz, Cathy Lee-Miller, Dmitry Baturin, Susan P Fosmire, Susan E Zelasko, Courtney L Jones, Jill E Slansky, Manali Rupji, Bhakti Dwivedi, Curtis J Henry, Christopher C Porter
IL12 Abrogates Calcineurin-Dependent Immune Evasion during Leukemia Progression. Cancer research 79 (14) (2019)
Jill E Slansky, Paul T Spellman
Alternative Splicing in Tumors - A Path to Immunogenicity? The New England journal of medicine 380 (9) (2019)
Lisa I Greene, Tullia C Bruno, Jessica L Christenson, Angelo D'Alessandro, Rachel Culp-Hill, Kathleen Torkko, Virginia F Borges, Jill E Slansky, Jennifer K Richer
A Role for Tryptophan-2,3-dioxygenase in CD8 T-cell Suppression and Evidence of Tryptophan Catabolism in Breast Cancer Patient Plasma. Molecular cancer research : MCR 17 (1) (2018)